QORENCE
DEAD

Serial Number

86019567

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 25, 2013

Add to watchlist:

No watchlists yet
View on USPTO

QORENCE Trademark

Serial Number: 86019567

QORENCE is a trademark filed by NOVARTIS AG on July 25, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 25, 2013

Registration Date

Not Registered

Published for Opposition

November 26, 2013

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Diagnostic preparations for medical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Vaccines

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 27, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 27, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 26, 2016 EXRA
SOU EXTENSION 5 GRANTED
Jul 25, 2016 EX5G
SOU EXTENSION 5 FILED
Jul 14, 2016 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 14, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2016 EXRA
SOU EXTENSION 4 GRANTED
Jan 27, 2016 EX4G
SOU EXTENSION 4 FILED
Jan 19, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 19, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2015 EXRA
SOU EXTENSION 3 GRANTED
Jul 23, 2015 EX3G
SOU EXTENSION 3 FILED
Jul 17, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 17, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2015 EXRA
SOU EXTENSION 2 GRANTED
Mar 3, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2015 AITU
SOU EXTENSION 2 FILED
Jan 19, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 19, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2014 EXRA
SOU EXTENSION 1 GRANTED
Jul 20, 2014 EX1G
SOU EXTENSION 1 FILED
Jul 20, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 20, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 21, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2013 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2013 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2013 CNSA
ASSIGNED TO EXAMINER
Oct 17, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2013 NWOS
NEW APPLICATION ENTERED
Jul 29, 2013 NWAP